155 related articles for article (PubMed ID: 9519818)
1. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection.
Geretti AM; Hulskotte E; Osterhaus AD
J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818
[No Abstract] [Full Text] [Related]
2. Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection.
O'Connor D; Friedrich T; Hughes A; Allen TM; Watkins D
Immunol Rev; 2001 Oct; 183():115-26. PubMed ID: 11782252
[TBL] [Abstract][Full Text] [Related]
3. AIDS vaccines show promise in primates.
Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
[No Abstract] [Full Text] [Related]
4. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
[TBL] [Abstract][Full Text] [Related]
5. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.
Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T
J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
[TBL] [Abstract][Full Text] [Related]
7. Vaccinology: Persistence pays off.
Johnson RP
Nature; 2011 May; 473(7348):456-7. PubMed ID: 21614068
[TBL] [Abstract][Full Text] [Related]
8. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
[TBL] [Abstract][Full Text] [Related]
10. Houdini's box: towards an understanding of AIDS virus escape from the cytotoxic T-lymphocyte response.
O'Connor DH; Watkins DI
Immunogenetics; 1999 Nov; 50(3-4):237-41. PubMed ID: 10602884
[No Abstract] [Full Text] [Related]
11. Transmission of simian immunodeficiency virus carrying multiple cytotoxic T-lymphocyte escape mutations with diminished replicative ability can result in AIDS progression in rhesus macaques.
Seki S; Kawada M; Takeda A; Igarashi H; Sata T; Matano T
J Virol; 2008 May; 82(10):5093-8. PubMed ID: 18337572
[TBL] [Abstract][Full Text] [Related]
12. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
[TBL] [Abstract][Full Text] [Related]
13. Vaccines. Monkey puzzles.
Cohen J
Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
[No Abstract] [Full Text] [Related]
14. Long-term non-progressive human immunodeficiency virus infection: new insights from the simian immunodeficiency virus model.
Dittmer U; Hunsmann G
J Gen Virol; 1997 May; 78 ( Pt 5)():979-84. PubMed ID: 9152413
[No Abstract] [Full Text] [Related]
15. Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus.
Sharpe SA; Whatmore AM; Hall GA; Cranage MP
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1923-7. PubMed ID: 9266989
[TBL] [Abstract][Full Text] [Related]
16. Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein.
Kano M; Matano T; Nakamura H; Takeda A; Kato A; Ariyoshi K; Mori K; Sata T; Nagai Y
AIDS; 2000 Jun; 14(9):1281-2. PubMed ID: 10894297
[No Abstract] [Full Text] [Related]
17. Alternative HIV vaccine strategies.
Lehner T; Shearer GM
Science; 2002 Aug; 297(5585):1276-7. PubMed ID: 12194176
[No Abstract] [Full Text] [Related]
18. Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.
Zhou D; Shen Y; Chalifoux L; Lee-Parritz D; Simon M; Sehgal PK; Zheng L; Halloran M; Chen ZW
J Immunol; 1999 Feb; 162(4):2204-16. PubMed ID: 9973496
[TBL] [Abstract][Full Text] [Related]
19. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
[TBL] [Abstract][Full Text] [Related]
20. [Live attenuated viruses: a new strategy for vaccination against AIDS].
Molina JM
Pathol Biol (Paris); 1993 Jun; 41(6):513-4. PubMed ID: 8247628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
